| |
NINDS Press Releases - Current
Study Using Robotic Microscope Shows How Mutant Huntington's Disease Protein Affects Neurons
Wednesday, October 13, 2004Using a specially designed robotic microscope to study cultured cells, researchers have found evidence that abnormal protein clumps called inclusion bodies in neurons from people with Huntington's disease (HD) prevent cell death. The finding helps to resolve a longstanding debate about the role of these inclusion bodies in HD and other disorders and may help investigators find effective treatments for these diseases. Fact Sheet
Reorganization of the Brain Allows Blind Individuals to Process Speech More EffectivelyMonday, October 04, 2004The portion of the brain devoted to vision may play a prominent role in processing the spoken word in blind people. Research conducted by the NIH's National Institute of Neurological Disorders and Stroke (NINDS) shows that the "sight" region of the brain is essentially reorganized in blind individuals to help them process spoken words more effectively. The findings yield important information about the brain's ability to compensate for lost function.
Small Trial Shows Daclizumab Add-On Therapy Improves Multiple Sclerosis Outcome
Monday, May 24, 2004A small clinical trial of patients with multiple sclerosis (MS) who did not respond to interferon alone found that adding the human antibody daclizumab improved patient outcome. Patients who received the combined therapy had a 78 percent reduction in new brain lesions and a 70 percent reduction in total lesions, along with other significant clinical improvements. Fact Sheet
Early Treatment Confirmed as Key to Stroke RecoveryThursday, March 04, 2004A study in the March 6, 2004, issue of The Lancet confirms the benefits of getting stroke patients to the hospital quickly for rapid thrombolytic treatment. The study provides the results of an extensive analysis of more than 2,700 stroke patients in six controlled clinical trials who were randomized for treatment with thrombolytic t-PA or a placebo. Fact Sheet
Press release archive Qualified media representatives can arrange interviews and photos with NINDS researchers and administrators. E-Mail or call (301) 496-5751. Office of Communications And Public Liaison Building 31, Room 8A-07 31 Center Drive MSC 2540 P.O. Box 5801 Bethesda, MD 20824 |
|